Close
San Antonio Liver Cancer Symposium
Friday, October 11, 2024
to
Saturday, October 12, 2024
Register now
-
About
About This Event
Mays Cancer Center at UT Health San Antonio invites you to our annual San Antonio Liver Cancer Symposium (SALCS) at the Hilton Palacio del Rio in downtown San Antonio on Oct. 11-12, 2024.
Join us for a two-day symposium filled with engaging sessions and interactive panel discussions to promote collaboration and advance liver cancer knowledge. This meeting will cover the epidemiology of liver cancer and explore the latest pre-clinical, translational and clinical breakthroughs in its treatment, encompassing survivorship care and pediatric liver cancer. We welcome the liver cancer community, along with physicians, researchers, nurses and providers, to participate and contribute to this enriching experience.
Topics include:
- Exploring pediatric management of hepatoblastoma, including its molecular signatures and novel therapies.
- Examining the controversies in transplantation.
- Growing community liver cancer programs to enhance patient care and support.
- Developing personalized programs for non-viral versus viral hepatitis/cirrhosis.
- Gaining insights into the current therapeutic landscape for hepatocellular carcinoma.
- Discussing the shifting paradigms in locoregional treatments: surgical advancements, interventional radiology and transplant innovations.
Why you should attend:
- Increase your knowledge of liver cancer treatment.
- Receive a comprehensive update on the latest scientific, clinical and translational advancements in liver cancer.
- Listen and participate in dynamic discussions led by clinicians and researchers.
- Connect with renowned experts in liver cancer who will be presenting at the conference.
- Earn CME, MOC and CNE credits.
The University of Texas Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas Health Science Center San Antonio designates this live activity AMA PRA Category 1 Credits™.
University Health is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
-
Agenda
Agenda
Friday, October 11 7:00 a.m. - 7:50 a.m. Registration, Breakfast and Exhibits 7:50 a.m. - 8:00 a.m. Welcome and Introductions Lei Zheng, MD, PhD, Executive Director
Mays Cancer Center at UT Health San AntonioSukeshi Arora, MD
Mays Cancer Center at UT Health San AntonioDanielle Fritze, MD
Mays Cancer Center at UT Health San AntonioSession 1 - Plenary 1 Moderator Sukeshi Arora, MD, associate professor, Division of Hematology and Oncology, and leader gastrointestinal malignancies program
Mays Cancer Center at UT Health San Antonio8:00 a.m. - 8:45 a.m. Journey of Hepatic Arterial Infusion Chemotherapy (HAIC) for Liver Tumors Nancy Kemeny, MD
Memorial Sloan Kettering Cancer Center
8:45 a.m. - 9:00 a.m. Q&A Session 2 - Liver Cancer Immunology Moderator(s) Christi Walter, PhD, professor and chair, Department of Cell Systems and Anatomy
UT Health San AntonioLuZhe Sun, PhD, professor, Department of Cell Systems and Anatomy, and associate director, basic research
Mays Cancer Center at UT Health San Antonio9:00 a.m. - 9:15 a.m. Targeting macrophages to improve anti-CTLA4 immunotherapy for Hepatocellular Cancer
Guangfu Li, PhD
University of Connecticut9:15 a.m - 9:30 a.m. Regulating Macrophage Activation: A Strategy to Mitigate Diet-induced Hepatic Inflammation and Tumor Formation
Lily Q. Dong, PhD
UT Health San Antonio9:30 a.m. - 9:45 a.m. CAR T-cell-based Triple-Hit Immunotherapy for Hepatocellular Carcinoma
Gang Huang, PhD
UT Health San Antonio9:45 a.m. - 10:00 a.m. T-Cell Exhaustion and Programmed Cell Death Protein 1 (PD-1) Therapy in Liver Cancer
Beicheng Sun, MD, PhD
Anhui Medical University10:00 a.m. - 10:15 a.m. Q&A 10:15 a.m. - 10:30 a.m. Break, Networking and Exhibits Session 3 - The Changing Landscape of Hepatocellular Carcinoma in the US Moderator(s) Eric Lawitz, MD, professor at UT Health San Antonio, medical director
Texas Liver Institute10:30 a.m. - 10:45 a.m. Future Screening Methods and Optimal Surveillance of Hepatocellular Carcinoma
Augusto Villanueva Rodriguez, MD, PhD
Mount Sinai10:45 a.m. - 11:00 a.m. Liver Transplantation for Hepatocellular Carcinoma: Milan and Beyond
Andres Gomez-Aldana, MD
UT Health San Antonio11:00 a.m. - 11:15 a.m. Paradigm Shift in the Treatment of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
Erin Spengler, MD
Audie L. Murphy VA Medical Center11:15 a.m. - 11:30 a.m. Q&A Session 4 - Hot Topics for Local Regional Therapy for Hepatocellular Carcinoma Moderator(s) Jorge Lopera, MD, chief, Interventional Radiology Section, Department of Radiology
Mays Cancer Center at UT Health San Antonio11:30 a.m. - 11:45 a.m. Interventional Radiology
Arthur Joseph, MD
Mays Cancer Center at UT Health San Antonio11:45 a.m. - 12:00 p.m. External Radiation Treatment Options as a Local Therapy for Hepatocellular Carcinoma
Lauren Henke, MD
University Hospitals (Cleveland, Ohio)12:00 p.m. - 12:15 p.m. Surgical Oncology
Jonathon Cullen, MD
Mays Cancer Center at UT Health San Antonio12:15 a.m. - 12:30 p.m. Q&A 12:30 p.m. - 1:30 p.m. Lunch: Meet the Professor and Breakout
Hematology and Medical Oncology Breakout - Meet the Professor, Julie Rowe, MD1:30 p.m. - 2:15 p.m. Awards: Top 3 Abstracts
ERX-315: A Potential Treatment Option for Hepatocellular Carcinoma (HCC)
Adriana Baker
UT Health San AntonioGenomic Signature Analysis and Survival Outcomes in Cholangiocarcinoma (CCA) using Oncology Research Information Exchange Network (ORIEN) Database
Riya Jayesh Patel
Roswell Park Comprehensive Cancer CenterUniversity of Buffalo
Cell-free DNA methylation biomarkers for evaluating prognosis and treatment response in patients with hepatocellular carcinoma
Shivani Mahajan
Helio Genomics2:15 p.m. - 2:30 p.m. Q&A Session 5 - Controversial Cases of Oligometastases to Liver, Colorectal, Pancreas, Neuroendocrine cancers Moderator(s) Neil Newman, MD, assistant professor, Department of Radiation Oncology
Mays Cancer Center at UT Health San AntonioColin Court, MD, PhD, assistant professor, Division of Surgical Oncology, director, Regional Therapies Program
Mays Cancer Center at UT Health San Antonio2:30 p.m. - 2:45 p.m. Interventional Radiology Therapy for Metastatic Liver Disease
Armeen Mahvash, MD
MD Anderson Cancer Center2:45 p.m. - 3:00 p.m. Radiation Oncology
Eric Miller, MD, PhD
Ohio State University Comprehensive Cancer Center3:00 p.m. - 3:15 p.m. Surgical Oncology
Caitlin McIntyre, MD
Mays Cancer Center at UT Health San Antonio3:15 p.m. - 3:30 p.m. Q&A 3:30 p.m. - 3:45 p.m. Break, Networking and Exhibits 3:45 p.m. - 5:00 p.m. Poster Reception 5:00 p.m. - 6:00 p.m. Evening Symposium 6:00 p.m. - Day 1 Adjourns Saturday, October 12 7:00 a.m. - 8:00 a.m. Registration, Breakfast and Exhibits Session 6 - Plenary 2 Moderator(s) LuZhe Sun, PhD, professor, Department of Cell Systems and Anatomy, and associate director, basic research
Mays Cancer Center at UT Health San Antonio8:00 a.m. - 8:45 a.m. Plenary 2
Building a Self-Learning System for Global Liver Cancer Control - Collaborative, Transformative, and Catalytic Innovation, Application, and Implementation
Lewis Roberts, MD, PhD
Mayo Clinic8:45 a.m. - 9:00 a.m. Q&A Session 7 - Multidisciplinary Care for Cholangiocarcinoma Moderator(s) Alex Parikh, MD, professor and chief, Division of Surgical Oncology
Mays Cancer Center at UT Health San Antonio9:00 a.m. - 9:15 a.m. Breaking Ground: Innovations in Cholangiocarcinoma Research
Milind Javle, MD
MD Anderson Cancer Center9:15 a.m. - 9:30 a.m. Surgical Oncology
Hop Tran Cao, MD
MD Anderson Cancer Center9:30 a.m. - 9:45 a.m. Definitive radiotherapy for unresectable cholangiocarcinoma
Eugene Koay, MD, PhD
MD Anderson Cancer Center9:45 a.m. - 10:00 a.m. Transplant Surgery
Adeel Khan, MD
University of Washington in St. Louis10:00 a.m. - 10:15 a.m. Q&A 10:15 a.m. - 10:30 a.m. Break, Networking and Exhibits Session 8 - Transplant Oncology: Present and Future Moderator(s) Tarunjeet Klair, MD, associate professor and director, Living Donor and Liver Transplantation Program
UT Health San Antonio10:30 a.m. - 10:45 a.m. Liver Transplant for Metastatic Colorectal Cancer
Roberto Hernandez-Alejandro, MD
University of Rochester Medical Center10:45 a.m. - 11:00 a.m. Liver Transplant and Immunotherapy
Maen Abdelrahim, MD, PhD, PharmB
Houston Methodist Neal Cancer Center11:00 a.m. - 11:30 a.m. Q&A 11:30 a.m. - 12:30 p.m. Lunch and Breakout
Advanced Practice Provider BreakoutSession 9 - 2024 Updates in Systemic Treatments for Hepatocellular Carcinoma Moderator(s) Sukeshi Arora, MD, associate professor and leader gastrointestinal malignancies program
Mays Cancer Center at UT Health San Antonio12:30 p.m. - 12:45 p.m. Systemic Therapy Advanced Hepatocellular Carcinoma
Anwaar Saeed, MD
The University of Pittsburgh12:45 p.m. - 1:00 p.m. Perioperative Therapies for Hepatocellular Carcinoma
Adam Yopp, MD
UT Southwestern Medical Center1:00 p.m. - 1:15 p.m. Q&A Session 10 - What Do We Do With Benign Liver Tumors? Moderator(s) Jean-Nicolas Vauthey, MD, FACS, professor and chief, Hepato-Pancreato-Billiary Section
MD Anderson Cancer CenterVenkat Katabathina, MD, PhD, director, Abdominal Imaging, Department of Radiology
UT Health San Antonio1:15 p.m. - 1:30 p.m. Diagnostic Imaging for Benign Liver Tumors
Venkat Katabathina, MD, PhD, director, Abdominal Imaging, Department of Radiology
UT Health San Antonio1:30 p.m. - 1:45 p.m. Management of Benign Liver Tumors
Jean-Nicolas Vauthey, MD, FACS, professor and chief, Hepato-Pancreato-Billiary Section
MD Anderson Cancer Center1:45 p.m. - 2:00 p.m. Q&A Session 11 - Supportive Care and the Caregiver Moderator(s) Sherri Cervantez, MD, assistant professor, Division of Hematology and Oncology and Division of Geriatrics, Gerontology and Palliative Medicine
Mays Cancer Center at UT Health San AntonioAndrea Wilson Woods
Blue Faery2:00 p.m. - 2:15 p.m. Identifying Caregiver Burden in Liver Cancer
Cristal Brown, MD
University of Texas at Austin, Dell Medical School2:15 p.m. - 2:30 p.m. Impact of Hepatic Encephalopathy and Liver Disease on Caregivers
Andrea Wilson Woods
Sharon Dixon
Blue FaeryIrma Gutierrez, Patient Advocate
Janelle Gutierrez, Patient Advocate2:30 p.m. - 2:45 p.m. Caregiver Support and Navigation Tools
Kelsey Mantz
University Health Transplant2:45 p.m. - 3:00 p.m. Joint Panel
Andrea Wilson Woods
Sharon Dixon
Blue FaeryIrma Gutierrez, Patient Advocate
Janelle Gutierrez, Patient AdvocateKelsey Mantz
University Health TransplantCristal Brown, MD
University of Texas at Austin, Dell Medical School3:00 p.m. - 3:15 p.m. Q&A 3:15 p.m. - 3:30 p.m. Break, Networking and Exhibits Session 12 - Liver 101: Guidelines and Recommendations for Primary Care Teams Moderator(s) Jan Petrasek, MD, PhD, assistant professor
UT Health San Antonio
Texas Liver Institute3:30 p.m. - 3:45 p.m. Jan Petrasek, MD, PhD, assistant professor
UT Health San Antonio
Texas Liver Institute3:45 p.m. - 4:00 p.m. Screening for Hepatocellular Carcinoma
Fabian Rodas-Ochoa, MD
UT Health San Antonio
Texas Liver Institute4:00 p.m. - 4:15 p.m. Contrast-Enhanced Ultrasonography of the Liver
Louis Mazzarelli, MD
Yale New Haven Health4:15 p.m. - 4:25 p.m. Q&A 4:25 p.m. - 4:35 p.m. - Closing Remarks Sukeshi Arora, MD, associate professor, Division of Hematology and Oncology, and leader gastrointestinal malignancies program
Mays Cancer Center at UT Health San Antonio4:35 p.m. - Symposium Adjourns -
Date and Time
Date and Time
- Friday, October 11, 2024, 7:00AM
- to Saturday, October 12, 2024, 3:30PM
-
Location
Location
-
Call for Abstracts
Call for Abstracts
DEADLINE: August 1, 2024
Abstract categories:
- Cancer disparities
- Diagnostics (including biomarkers and precision medicine)
- Patient-reported outcomes and real-world evidence
- Pediatrics
- Prevention and screening
- Surgical management
- Survivorship
- Therapeutics (i.e., interventional, radiation and systemic)
- Translational research
- Tumor biology, biomarkers and pathology
- Other
Abstract instructions:
- Abstracts must include all authors and their institutions.
- Disclosure information for all authors must be included.
- Identify the lead author with an asterisk.
- Awards will be offered, and the top three posters will be presented during the symposium on Friday, October 11, 2024.
- Up to three references are allowed. These should be cited numerically in the text and placed under “References Cited” with titles included.
- Abbreviations can be used as long they are defined at their first mention in the text.
- The author and institution list is not included in the character limit.
- The lead/primary author listed on the abstract must be registered and present at the conference.
- Accepted abstracts - presenters will be notified by e-mail in September 2024.
- Presenters are responsible for producing and printing their posters if they are accepted for a poster. The Instructions for the poster printing will be sent to accepted abstracts.
- All accepted posters will be able to be presented during the evening poster session on Friday, October 11, 2024.
-
Contact
Contact
For questions about the symposium, please send an email to UTHealthMTG@uthscsa.edu.
-
Exhibitor Details
Exhibitor Details
If you want to exhibit at the San Antonio Liver Cancer Symposium, CLICK HERE to submit your application.
For all other questions, please send an email to UTHealthMTG@uthscsa.edu.